Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Anastrazole 1mg Film Coated Tablet – PA0749/028/001
- Epipen Junior 150mg Solution in a Prefilled Pen – PA2010/062/001
- Esomeprazole Ticerin 40mg Powder for Solution for Injection or Infusion – PA1852/002/001
- Ezetimibe Teva 10mg Tablet – PA1986/012/001
- Isoptin 240mg Prolonged Release Tablet – PA2010/003/005
- Minulet 75mcg/30mcg Coated Tablet – PA0822/093/001
- Mozobil 20micromole Solution for Injection – EU/1/09/537/001
- Rifidin 150mg Capsule – PA0540/066/001
- Scheriproct Ointment – PA1025/011/001
The following shortages have been resolved and supply has resumed to the Irish market:
- Blopress 16mg Tablet – PA2229/001/004
- Candist 8mg Tablet – PA0126/206/002
- Colomycin Injection 1 Million IU Solution for Injection, Infusion or Inhalation – PA1986/046/001
- Deprager 100mg Film Coated Tablet – PA0577/067/002
- Flucol 150mg Hard Capsule – PA0711/057/003
- Montelair 5mg Chewable Tablet – PA0126/215/002
- Perdamel 1mg Film Coated Tablet – PA0126/169/003
- Salazopyrin 500mg Tablet – PA0822/196/002
- Serlan 50mg Film Coated Tablet – PA0711/065/001
- Temozolomide 140mg Capsule – EU/1/09/606/007-008
- Tradol SR 100mg Prolonged Release Tablet – PA0711/029/005
- Vedixal 37.5mg Tablet – PA0711/161/002
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.